Moderna
-
healthWHO Slashes Congo Ebola Count to 116; Vaccine Race Intensifies
WHO drastically revises suspected Ebola cases in Congo down to 116, from over 1,000, as testing clarifies other diseases. Five patients recover.
-
healthmRNA Vaccine Slashes Melanoma Recurrence Risk in Landmark Trial
A new mRNA cancer therapy from Merck and Moderna cuts melanoma recurrence or death risk by 49% over five years, offering new hope for late-stage patients.
-
healthCEPI Grants $61.8 Million to Accelerate Ebola Vaccine Development
CEPI awards $61.8M to Moderna, Oxford, and IAVI for rapid development of vaccines against the Bundibugyo Ebola strain.
-
healthModerna Receives $50 Million to Develop mRNA Ebola Vaccine
CEPI funds Moderna, IAVI, and Oxford to develop vaccines against the deadly Bundibugyo Ebola strain currently raging in the DRC.
-
healthRush to Develop Ebola Vaccines as Deadly Outbreak Spreads
The Bundibugyo Ebola species has killed nearly 250 people. Three vaccines are in development as fears grow of a major epidemic.
-
healthGlobal Health Funders Fast-Track Three Ebola Vaccines as Outbreak Spreads in Africa
CEPI accelerates development of three Ebola vaccines as Bundibugyo virus spreads in DRC and Uganda, with up to $50 million for Moderna's mRNA candidate.
-
healthHantavirus Vaccine Remains Years Away Despite Outbreak
No approved vaccine for hantavirus exists, as experts warn of lengthy trials despite recent outbreak.
-
healthHantavirus Outbreak: Conspiracy Theories Debunked Amid Moderna Vaccine Claims
Fact-checking hantavirus origin, Moderna's role, ivermectin efficacy, and baseless Israeli hoax allegations. Three dead in MV Hondius outbreak.